# Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.

> **NCT00151944** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 400 (—)

## Conditions studied

- Colitis, Ulcerative

## Interventions

- **DRUG:** SPD476 (mesalazine)

## Key facts

- **NCT ID:** NCT00151944
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11-26
- **Primary completion:** 2006-03-13
- **Final completion:** 2006-03-13
- **Target enrollment:** 400 (—)
- **Last updated:** 2021-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151944, "Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00151944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*